Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Book Review
Brief Report
Case Report
Case Series
Commentary
Editorial
Erratum
Guest Editorial
Images
Images in Neurology
Images in Neuroscience
Images in Neurosciences
Letter to Editor
Letter to the Editor
Letters to Editor
Letters to the Editor
Media and News
None
Notice of Retraction
Obituary
Original Article
Point of View
Position Paper
Review Article
Short Communication
Technical Note
Techniques in Neurosurgery
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Book Review
Brief Report
Case Report
Case Series
Commentary
Editorial
Erratum
Guest Editorial
Images
Images in Neurology
Images in Neuroscience
Images in Neurosciences
Letter to Editor
Letter to the Editor
Letters to Editor
Letters to the Editor
Media and News
None
Notice of Retraction
Obituary
Original Article
Point of View
Position Paper
Review Article
Short Communication
Technical Note
Techniques in Neurosurgery
View/Download PDF

Translate this page into:

Review Article
2 (
1
); 56-61
doi:
10.4103/0976-3147.80102

Effect of plant extracts on Alzheimer's disease: An insight into therapeutic avenues

Address for correspondence: M. Obulesu, Department of Biotechnology, Rayalaseema University, Kurnool, Andhra Pradesh
Licence

This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Disclaimer:
This article was originally published by Medknow Publications and was migrated to Scientific Scholar after the change of Publisher; therefore Scientific Scholar has no control over the quality or content of this article.

Source of Support: Nil

Conflict of Interest: None declared.

Abstract

Alzheimer's disease (AD) is a devastative neurodegenerative disorder which needs adequate studies on effective treatment options. The extracts of plants and their effect on the amelioration of AD symptoms have been extensively studied. This paper summarizes the mechanisms like acetylcholinesterase (AChE) inhibition, modification of monoamines, antiamyloid aggregation effect, and antioxidant activity which are actively entailed in the process of amelioration of AD symptoms. These effects are induced by extracts of a few plants of different origin like Yizhi Jiannao, Moringa oleifera (Drumstick tree), Ginkgo Biloba (Ginkgo/Maidenhair tree), Cassia obtisufolia (Sicklepod), Desmodium gangeticum (Sal Leaved Desmodium), Melissa officinalis (Lemon Balm), and Salvia officinalis (Garden sage, common sage).

Keywords

Alzheimer's disease
antiamyloid aggregation
antioxidants
acetyl choline esterase inhibitors
plant extracts.

Introduction

Alzheimer's association estimated that one in eight Americans above age of 65 years and half of the Americans above age of 85 years have been presently suffering from this devastative neurodegenerative disorder.[1] According to this estimation, the number of patients may reach 16 million by 2050[14] thus augmenting the economic cost of Alzheimer's disease (AD) health care system, which is 80-100 billion dollars presently.[1] Loss of cholinergic synapses in hippocampus and neocortex has been a consistent finding in AD, thus accentuating the need to employ a substantial strategy that regulates the AChE function to combat this defect.[1] Tacrine, donepezil, and rivastigmine are a few AChE inhibitors approved by U.S. Food and Drug Administration for the amelioration of AD symptoms.[156] Although advent of such inhibitors has been effective in function yet there has been augmenting need to quest for new drugs.[1] In the light of this fact, polyphenolic compounds from fruits and vegetables have been exploited because of their potential antioxidative properties.[1712] There has been growing focus on traditional herbal medicines presently since the failure of existing treatments.[13] The first neurotransmitter found to be involved in AD is acetylcholine.[14] Therefore, there have been manifold studies to employ AChE inhibitors.

Plants provide wealth of bioactive compounds, which exert a substantial strategy for the treatment of neurological disorders such as Alzheimer's disease.[15] It has been recently shown that a Chinese herb, Yizhi Jiannao Granules is effective in improving AD symptoms, and it also aggravates such amelioration when combined with acupuncture.[16] Zeatin has been found to have a protective role against Aβ-induced neurotoxicity in PC12 cells and ameliorate scopolamine-induced amnesia in ICR mice.17

Cholinesterase Inhibition

Growing lines of evidence suggests that among 73 native and naturalized plants collected from the central region of Argentina, organic fractions obtained from extracts of Achyrocline tomentosa (Marcela) (Asteraceae), Eupatorium viscidum (Common boneset) (Asteraceae), Ruprechtia apetala (manzano del campo) (Polygonaceae), Trichocline reptans (arnica) (Asteraceae), and Zanthoxylum coco (cochucho, coco) (Rutaceae) demonstrated substantial inhibition of AChE (higher than 80%)[Table 1].[15] Poncirus trifoliate (Trifoliate Orange) extract has been shown to inhibit AchE considerably.[1] Methoxsalen isolated from medicinal herbs Treculia obovoidea (Catterall) and Angelica archangelica (Garden Angelica), shows antimicrobial and anti-AchE activities in vitro.[1181920]

Table 1: Neuroprotective mechanisms exerted by various plant extracts

Studies on the seeds of Cassia obtisufolia proved their neuroprotective role in mice via attenuation of secondary Ca2+ dysregulation and mitochondrial toxin 3-NP.[13] Moreover, they can improve memory impairment via AChE inhibition.[1321] Flavonoids, a group of phenolic compounds which demonstrate antimutagenic, anticarcinogenic, and antiageing properties[22232425] may be responsible for neuroprotective role of Cassia obtusifolia extracts.[13] Dried ginger has been shown to induce Ca2+ antagonistic activity and butylcholinesterase inhibitory activity which are effective in AD treatment.[26]

Modification of Monoamines

Moringa oleifera (MO) which belongs to the family Moringaceae, is prevalent almost all over the Asian and African countries. Its fruit and leaves which show anti-inflammatory and hypotensive effect are consumed as food by the people.[2729] It has been found recently that Moringa oleifera leaf extract which is not toxic even at higher concentration levels, enhances memory via nootropics activity and provides substantial antioxidants like vitamin C and E to combat oxidative stress in AD.[273032] Wealth of studies substantiated that monoamines entailed in the memory loss are altered by Moringa oleifera leaf extracts [Table 1].[2733] Several lines of evidence also suggest that colchicines-induced AD can be ameliorated by ethanolic extract of Moringa oleifera by modifying the brain monoamines (norepinephrine, dopamine, and serotonin) and electrical activity in a rat model.[27]

Antiamyloid Aggregation Effect

Ginkgo biloba being a potential store house of antioxidants offers ample of health benefits to AD patients like antiamyloid aggregation effect [Table 1].[3436] Extensive studies on Ginkgo biloba revealed that 240 mg of Ginkgo biloba per day can decrease the incidence of AD.[34] Although there are a few substantial studies on Ginkgo biloba to ameliorate AD symptoms and worldwide sales of it exceed $249 million annually in the United States,[34] yet there has been augmenting need to initiate more promising clinical trials in this direction.[34] It has been found that the Ginkgo biloba extracts ameliorate cognitive defects in a mouse model of AD (Tg2576).[3738] Manifold clinical trials proved amelioration of AD symptoms[3940] and the clinical evaluation of EGb 761 that is widely used for dementia in many countries and an extensively used dietary supplement in the United States for memory enhancement,[4144] is presently in progress.[45] Although in vivo mechanism for EGb 761 is elusive yet it has been found to ameliorate AD symptoms both in vivo (AD mice Tg 2576)[46] and in vitro.[36374751] Upregulation of a small APP release, a nontoxic, nonamyloidogenic metabolite of APP, via a PKC-independent manner in hippocampi and cortices of EGb761-treated rats has been studied.[3752]

Antioxidants

Desmodium gangeticum generally known as Salparni, is prevalent in India and has significant medicinal use as a bitter tonic, febrifuge, digestive, anticatarrhal, antiemetic,[5354] and anti-inflammatory conditions.[5355] Moreover, it has been extensively used in ayurveda for the amelioration of neurological symptoms.[53] Its extracts employed in mice to evaluate the efficacy in amelioration of AD symptoms via nootropic activity and deterioration of AChE activity yielded considerable outcome.[53] It also possesses antioxidative property [Table 1].[5356]

Rosmarinic acid isolated from Salvia officinalis, attenuates a number of events provoked by Aβ-like reactive oxygen species formation, lipid peroxidation, DNA fragmentation, caspase-3 activation, and tau protein hyperphosphorylation.[5758] Despite a few pharmacological activities of sage attributed[59] to AD include antioxidant activity,[60] anti-inflammatory effects[61] and cholinesterase inhibition,[62] yet the mode of sage-protective action is unclear.[57] Rosmarinic acid has been known to initiate antioxidant, anti-inflammatory, antimutagen, antibacterial, and antiviral properties.[63] Rosmarinic acid effectively inhibits hall mark events of AD-like formation of fibrils from Aβ, destabilization preformed Aβ fibrils in vitro and tau hyperphosphorylation.[5764]

Neuroprotective Effect of Traditional Japanese-Chinese, Korean, and European Plant Extracts

Kihi-to, a traditional Japanese-Chinese traditional medicine, shows significant amelioration of Aβ(25–35)-induced impairments in memory acquisition, memory retention, and object recognition memory in mice. It also attenuates neuritic, synaptic, and myelin losses in the cerebral cortex, hippocampus and striatum. Kihi-to also effectively attenuates the calpain augmentation in the cerebral cortex and hippocampus.[65] Abundance of research revealed that among several traditional Chinese medicines, Ginseng Radix[6667] Astragali Radix[68] and Polygalae Radix[69] demonstrated potential axonal extension activity against amyloid β (Aβ) (25–35)-induced axonal atrophy.[65]

Among the 90 traditional Korean tea plants, methanolic extracts of Pueraria thunbergiana (Kudzu) rich in Daidzein (4,7 dihydroxy isoflavone), are actively entailed in the amelioration of scopolamine induced amnesia in mice.[70] Abundance of research unraveled the neuroprotective effect of Gossypium Herbaceam extracts against ibotenic acid induced learning and memory impairment in rats.[71]

Melissa officinalis extract has been proven to ameliorate mild to moderate AD.[14] Among the European herbs M. officinalis and another herb in the labiatae family, S. officinalis, might present a natural treatment for AD by amelioration of cognition.[145872] This herb actively amends mood and cognitive ability during acute administration in healthy young volunteers and has no side effects or symptoms of toxicity.[14737475] S. triloba (Greek Sage) and Teucrium polium (Cat Thyme) are also effective in amelioration of AD symptoms.[76]

Ayurvedic Plants and AD

Formulation of some Indian medicinal plants classified in Ayurveda, the classic Indian system of medicine, as Medhyarasayanas or drugs considerably ameliorates memory and intellect.[7778] Studies on rats demonstrated that the oral administration of Trasina, a herbal formulation, once daily for 21 days can effectively ameliorate colchicine induced effects like reduced frontal, cortical and hippocampal acetylcholine (Ach) concentrations, choline acetyltransferase (ChAT) activity, and muscarinic cholinergic receptor (MCR) binding.[77] It has been reported recently that alcoholic extract of Bacopa monnieri (Water Hyssop) significantly improves escape latency time in Morris water maze test and ameliorates reduction of neurons and cholinergic neuron densities in Wistar rats which are employed as AD animal models.[79] Anwala churna (Emblica officinalis Gaertn.), an Ayurvedic preparation showed an exemplary improvement in memory and brain cholinesterase activity, thus ameliorating the scopolamine induced amnesia in young and aged mice.[80]

Curcumin

Curcuma longa (Turmeric) has been the source of Curcumin (diferuloylmethane), an orange–yellow component of turmeric or curry powder. This being a potential polyphenol natural product has been predominantly used in some medicinal preparation or used as a food-coloring agent. Wealth of studies in vitro and in vivo substantiated that curcumin has anticancer, antiviral, antiarthritic, anti-amyloid, antioxidant, and anti-inflammatory properties. The molecular underpinnings of these effects have been found to involve the regulation of diverse molecular targets, including transcription factors (such as nuclear factor-κB), growth factors (such as vascular endothelial cell growth factor), inflammatory cytokines (such as tumor necrosis factor, interleukin 1 and interleukin 6), protein kinases (such as mammalian target of rapamycin, mitogen-activated protein kinases, and Akt) and other enzymes (such as cyclooxygenase 2 and 5 lipoxygenase). Its ability to regulate multiple targets and its safety for human use, made curcumin an amenable therapeutic agent for the prevention and/or treatment of various malignant diseases, arthritis, allergies, AD, and other inflammatory illnesses.[81]

Recent studies on cultured astrocytes obtained from pregnant Sprague-Dawley (SD) rat and neonatal 0–2-day-old SD rats showed improved neuronal survival by curcumin treatment in NMDA toxicity through the activation of PI3K/MAPK signaling pathways.[82] Studies employing surface plasmon resonance experiments, unraveled that the liposomes exposing the curcumin derivative (maintaining the planarity) demonstrate considerable affinity for Aβ1-42 fibrils (1–5 nM), through the exhibition of multivalent interactions, thus opening an amenable therapeutic avenue unlike the nonplanar curcumin.[83]

Conclusion

There have been manifold studies to combat this dreadful neurodegenerative disorder for a few decades. Although a few drugs are available today for the management of AD and many plants and their extracts are extensively employed in animal studies and AD patients, yet no substantial drug or plant extract is able to reverse the AD symptoms adequately. The intervention of phytotherapy, which entails the use of herbal medicines may be a potential corner stone based on which treatment strategies can be streamlined.[148486] It is tangible that there has been augmenting need for such therapeutic intervention.

References

  1. , , , , , , . Inhibitory effect of poncirus trifoliate on acetyl cholinesterase and attenuating activity against trimethyltin induced learning and memory impairment. Biosci Biotechnol Biochem. 2009;73:1105-12.
    [Google Scholar]
  2. , , , , , , . Naringenin from Citrus junos has an inhibitory effect on acetylcholinesterase and a mitigating effect on amnesia. Dement. Geriatr. Cogn Disord. 2004;17:151-7.
    [Google Scholar]
  3. , , , , , , . Multiple antioxidants in the prevention and treatment of Alzheimer disease: Analysis of biologic rationale. Clin Neuropharmacol. 2000;23:2-13.
    [Google Scholar]
  4. , , . Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Ann Neurol. 1991;30:572-80.
    [Google Scholar]
  5. , , , , , , . Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's diseases. J Neurol Sci. 1983;59:277-89.
    [Google Scholar]
  6. , , , , . Natural products and their derivatives as cholinesterase inhibitors in the treatment of neurodegenerative disorders: An update. Curr Med Chem. 2008;12:1209-28.
    [Google Scholar]
  7. , , . Antioxidant and radical scavenging properties of curcumin. Chem Biol Interact. 2008;174:27-37.
    [Google Scholar]
  8. , . Antioxidant activity of caffeic acid (3,4-dihydroxycinnamic acid) Toxicology. 2006;217:213-20.
    [Google Scholar]
  9. , , . Antioxidant and antiradical activities of flavonoids. J Agric Food Chem. 2001;49:2774-9.
    [Google Scholar]
  10. , , , , . Antitumor activity of some natural flavonoids and synthetic derivatives on various human and murine cancer cell lines. Bioorg Med Chem. 2006;14:2966-71.
    [Google Scholar]
  11. , , , , . Comparative evaluation of cytotoxicity and antioxidative activity of 20 flavonoids. J Agric Food Chem. 2008;56:3876-83.
    [Google Scholar]
  12. , , , , , , . Bioactive compounds in foods: Their role in the prevention of cardiovascular disease and cancer. Am J Med. 2002;113:71S-88S.
    [Google Scholar]
  13. , , , , , , . The seed extract of cassia obtusifolia offers neuroprotection to mouse hippocampal cultures. J Pharmacol Sci. 2008;107:380-92.
    [Google Scholar]
  14. , , , , , , . Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: A double blind, randomised, placebo controlled trial. J Neurol Neurosurg Psychiatry. 2003;74:863-6.
    [Google Scholar]
  15. , , , , . Screening for acetylcholinesterase inhibitory activity in plant extracts from Argentina. Phytother Res. 2009;24:259-63.
    [Google Scholar]
  16. , , . Clinical observation on acupuncture combined with Yizhi Jiannao granules for treatment of Alzheimer's disease. Zhongguo Zhen Jiu. 2009;29:269-71.
    [Google Scholar]
  17. , , , , , , . Zeatin prevents amyloid beta-induced neurotoxicity and scopolamine-induced cognitive deficits. J Med Food. 2009;12:271-7.
    [Google Scholar]
  18. , , , , , , . Antimicrobial activity of the crude extracts and compounds from Ficus chlamydocarpa and Ficus cordata (Moraceae) J Ethnopharmacol. 2008;120:17-24.
    [Google Scholar]
  19. , , . Antimicrobial activity of the crude extracts and compounds from Ficus chlamydocarpa and Ficus cordata (Moraceae) Z Naturforsch C. 2007;62:689-93.
    [Google Scholar]
  20. , , , , , , . Antioxidant activity of citrus limonoids, flavonoids, and coumarins. J Agric Food Chem. 2005;53:2009-14.
    [Google Scholar]
  21. , , , , , , . The seed extract of cassia obtusifolia ameliorates learning and memory impairments induced by scopolamine or transient cerebral hypoperfusion in mice. J Pharmacol Sci. 2007;105:82-93.
    [Google Scholar]
  22. , , , , , , . Oxygen species scavenging activity of phenolic extracts from hawthorn fresh plant organs and pharmaceutical preparations. Arzneimittelforschung. 1996;46:1086-9.
    [Google Scholar]
  23. , , , , , , . Phenolic constituents and antioxidant capacities of crataegus monogyna (hawthorn) callus extracts. Nahrung. 2003;47:191-8.
    [Google Scholar]
  24. , , , , . Quantitative structure-activity relationship analysis of phenolic antioxidants. Free Radic Biol Med. 1999;26:285-94.
    [Google Scholar]
  25. , , , , . Antioxidant activities of phenolic, proanthocyanidin, and flavonoid components in extracts of cassia fistula. J Agric Food Chem. 2002;50:5042-7.
    [Google Scholar]
  26. , , , , , , . Muscarinic, Ca(++) antagonist and specific butyrylcholinesterase inhibitory activity of dried ginger extract might explain its use in dementia. J Pharm Pharmacol. 2008;60:1375-83.
    [Google Scholar]
  27. , , . Alteration of brain monoamines and EEG wave pattern in rat model of Alzheimer's disease and protection by Moringa oleifera. Indian J Med Res. 2008;128:744-51.
    [Google Scholar]
  28. , , , , , , . Fully acetylated carbamates and hypotensive thiocarbamate glycosides from Moringa oleifera. Phytochemistry. 1995;38:957-63.
    [Google Scholar]
  29. , , , , , , . Pharmacological properties of Moringa oleifera.2: Screening for antispasmodic, anti-inflammatoryand diuretic activity. J Ethnopharmacol. 1992;36:233-7.
    [Google Scholar]
  30. , , , , . Evaluation of hematological and hepatorenal functions of methanolic extract of Moringa oleifera Lam.root treated mice. Indian J Exp Biol. 1999;37:612-4.
    [Google Scholar]
  31. , , , , , , . Nootropic activity of Moringa oleifera leaves. J Nat Remedies. 2005;5:59-62.
    [Google Scholar]
  32. , , , , . Effect of Moringa oleifera in experimental model of Alzheimer's disease: Role of antioxidants. Ann Neurosci. 2005;12:36-9.
    [Google Scholar]
  33. , , . Protective role of an Indian herb, Moringa oleifera in memory impairment by high altitude hypoxic exposure: Possible role of monoamines. Biogenic Amines. 2006;20:121-33.
    [Google Scholar]
  34. , , , , , , . Ginkgo biloba for prevention of dementia a randomized controlled trial. JAMA. 2008;300:2253-62.
    [Google Scholar]
  35. , , , , . Cardioprotective and anti-oxidant effects of the terpenoid constituents of Ginkgo biloba extract (EGb 761) J Mol Cell Cardiol. 1997;29:733-42.
    [Google Scholar]
  36. , , , , , , . Inhibition of amyloid-beta aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761. Proc Natl Acad Sci USA. 2002;99:12197-202.
    [Google Scholar]
  37. , , , , , . EGb 761 enhances adult hippocampal neurogenesis and phosphorylation of CREB in transgenic mouse model of Alzheimer's disease. FASEB J. 2007;21:2400-8.
    [Google Scholar]
  38. , , , , , , . Effect of a short- and long-term treatment with Ginkgo biloba extract on amyloid precursor protein levels in a transgenic mouse model relevant to Alzheimer's disease. Arch Biochem Biophys. 2009;481:177-82.
    [Google Scholar]
  39. , , . Ginkgo biloba extract (EGb 761) and CNS functions: basic studies and clinical applications. Curr Drug Targets. 2000;1:25-58.
    [Google Scholar]
  40. , , . Studies on molecular mechanisms of Ginkgo biloba extract. Appl Microbiol Biotechnol. 2004;64:465-72.
    [Google Scholar]
  41. , , , , , , . A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia: North American EGb Study Group. J Am Med Assoc. 1997;278:1327-32.
    [Google Scholar]
  42. , , , . The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease. Arch Neurol. 1998;55:1409-15.
    [Google Scholar]
  43. , , . A double-blind, placebo-controlled, randomized trial of Ginkgo biloba extract EGb 761(R) in a sample of cognitively intact older adults: Neuropsychological findings. Hum Psychopharmacol. 2002;17:267-77.
    [Google Scholar]
  44. , , , , . Ginkgo biloba and donepezil: A comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled doubleblind study. Eur J Neurol. 2006;13:981-5.
    [Google Scholar]
  45. , , , , , , . The Ginkgo Evaluation of Memory (GEM) study: Design and baseline data of a randomized trial of Ginkgo biloba extract in prevention of dementia. Contemp Clin Trials. 2006;27:238-53.
    [Google Scholar]
  46. , , , , , , . Prevention of age-related spatial memory deficits in a transgenic mouse model of Alzheimer's disease by chronic Ginkgo biloba treatment. Exp Neurol. 2003;184:510-20.
    [Google Scholar]
  47. , , , . The Ginkgo biloba extract (EGb 761) protects and rescues hippocampal cells against nitric oxide-induced toxicity: Involvement of its flavonoid constituents and protein kinase C. J Neurochem. 2000;74:2268-77.
    [Google Scholar]
  48. , , , . The Ginkgo biloba extract EGb 761 rescues the PC12 neuronal cells from beta-amyloid-induced cell death by inhibiting the formation of beta-amyloid-derived diffusible neurotoxic ligands. Brain Res. 2001;889:181-90.
    [Google Scholar]
  49. , , . Bioflavonoid-rich botanical extracts show antioxidant and gene regulatory activity. Ann N Y Acad Sci. 2002;957:70-7.
    [Google Scholar]
  50. , , , , , , . Anti-apoptotic properties of Ginkgo biloba extract EGb 761 in differentiated PC12 cells. Cell Mol Biol (Noisy-le-grand). 2002;48:699-707.
    [Google Scholar]
  51. , , , . Modulation of pro-survival Akt/protein kinase B and ERK1/2 signaling cascades by quercetin and its in vivo metabolites underlie their action on neuronal viability. J Biol Chem. 2003;278:34783-93.
    [Google Scholar]
  52. , , , , , , . Amyloid precursor protein metabolism is regulated toward alpha-secretase pathway by Ginkgo biloba extracts. Neurobiol Dis. 2004;16:454-60.
    [Google Scholar]
  53. , , . Antiamnestic effects of Demodium gangeticum in mice. Yakugaku Zasshi. 2006;126:795-804.
    [Google Scholar]
  54. , , , . Glossary of Indian Medicinal Plants. New Delhi: Council of Scientifi c and Industrial Research; .
    [Google Scholar]
  55. , , , , . Gangetinin and desmodin, two minor pterocarpanoids of Desmodium gangeticum. Phytochemistry. 1975;14:1129-30.
    [Google Scholar]
  56. , , , , , , . Studies on the antioxidant activities of Desmodium gangeticum. Biol Pharm Bull. 2003;26:1424-7.
    [Google Scholar]
  57. , , , , , . The spice sage and its active ingredient rosmarinic acid protect PC12 Cells from amyloid: Peptide-induced neurotoxicity. J Pharmacol Exp Ther. 2006;317:1143-9.
    [Google Scholar]
  58. , , , , , . Medicinal plants and Alzheimer's disease: From ethnobotany to phytotherapy.J Pharm. Pharmacol. 1999;51:527-34.
    [Google Scholar]
  59. , , , . Plants with traditional uses and activities, relevant to the management of Alzheimer's disease and other cognitive disorders. Phytother Res. 2003;17:1-18.
    [Google Scholar]
  60. , , , , , , . Protective effects of the aerial parts of Salvia officinalis, Melissa officinalis and Lavandula angustifolia and their constituents against enzyme-dependent and enzyme-independent lipid peroxidation. Planta Med. 1999;65:576-8.
    [Google Scholar]
  61. , , , , , , . Topical anti-inflammatory activity of Salvia officinalis L.leaves: The relevance of ursolic acid. J Ethnopharmacol. 2001;75:125-32.
    [Google Scholar]
  62. , , , , , . European herbs with cholinergic activities: potential in dementia therapy. Int J Geriatr Psychiatry. 1996;11:1063-9.
    [Google Scholar]
  63. , , . Rosmarinic acid. Phytochemistry. 2003;62:121-5.
    [Google Scholar]
  64. , , , , . Curcumin has potent antiamyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro. J Neurosci Res. 2004;15:742-50.
    [Google Scholar]
  65. , , , . Kihi-to, a herbal traditional medicine, improves A beta (25-35)-induced memory impairment and losses of neuritis and synapses. BMC Compl Alternat Med. 2008;8:49.
    [Google Scholar]
  66. , , , , , . Axonal and dendritic extension by protopanaxadiol-type saponins from ginseng drugs in SK-N-SH cells. Jpn J Pharmacol. 2002;90:254-62.
    [Google Scholar]
  67. , , , , , . Aβ(25-35)-induced memory impairment, axonal atrophy, and synaptic loss are ameliorated by M1, A metabolite of protopanaxadiol- type saponins. Neuropsychopharmacology. 2004;29:860-8.
    [Google Scholar]
  68. , , , , . Promotion of axonal maturation and prevention of memory loss in mice by extracts of Astragalus mongholicus. Br J Pharmacol. 2006;149:532-41.
    [Google Scholar]
  69. , , . Characterization of anti-neurodegenerative effects of Polygala tenuifolia in Aβ(25-35)-treated cortical neurons. Biol Pharm Bull. 2006;29:1892-6.
    [Google Scholar]
  70. , , , , , , . Daidzein activates choline acetyltransferase from mc-IXC cells and improves drug-induced amnesia. Biosci Biotechnol Biochem. 2006;70:107-11.
    [Google Scholar]
  71. , , , , , , . Gossypium herbaceam extracts attenuate ibotenic acid-induced excitotoxicity in rat hippocampus. J Alzheimers Dis. 2009;16:331-9.
    [Google Scholar]
  72. , , , , , . Medicinal plants and Alzheimer's disease: Integrating ethnobotanical and contemporary scientific evidence. J Altern Complement Med. 1998;4:419-28.
    [Google Scholar]
  73. , , , . Rational phytotherapy: A physician's guide to herbal medicine. 1998
    [Google Scholar]
  74. , , , , , , . CNS acetylcholine receptor activity in European medicinal plants traditionally used to improve failing memory. J Ethnopharmacol. 2000;69:105-14.
    [Google Scholar]
  75. , , , , , . Modulation of mood and cognitive performance following acute administration of Melissa officinalis (lemon balm) Pharmacol Biochem Behav. 2002;72:953-64.
    [Google Scholar]
  76. , , . Appraisal of scopolamine-induced antiamnesic effect in mice and in vitro antiacetylcholinesterase and antioxidant activities of some traditionally used Lamiaceae plants. J Ethnopharmacol. 2009;122:327-32.
    [Google Scholar]
  77. , , . Effect of Trasina, an ayurvedic herbal formulation, on experimental models of Alzheimer's disease and central cholinergic markers in rats. J Altern Complement Med. 1997;3:327-36.
    [Google Scholar]
  78. , . Potential medicinal plants for CNS disorders: An overview. Phytother Res. 2006;20:1023-35.
    [Google Scholar]
  79. , , , , . Cognitive enhancement and neuroprotective effects of Bacopa monnieri in Alzheimer's disease model. J Ethnopharmacol. 2010;127:26-31.
    [Google Scholar]
  80. , , . Memory enhancing activity of Anwala churna (Emblica officinalis Gaertn.): An Ayurvedic preparation. Physiol Behav. 2007;91:46-54.
    [Google Scholar]
  81. , , , . The targets of curcumin. Curr Drug Targets. 2011;12:332-47.
    [Google Scholar]
  82. , , , , , , . Curcumin enhances neuronal survival in N-methyl-D-aspartic acid toxicity by inducing RANTES expression in astrocytes via PI-3K and MAPK signaling pathways. 2011
    [Google Scholar]
  83. , , , , , , . Curcumin-decorated nanoliposomes with very high affinity for amyloid-β1-42 peptide. Biomaterials. 2011;32:1635-45.
    [Google Scholar]
  84. , , . Alzheimer's disease: Pathophysiology and pharmacotherapy. I Drugs. 2002;4:1167-72.
    [Google Scholar]
  85. , . New drugs for Alzheimer's disease and other dementias. Br J Psychiatry. 2002;180:135-9.
    [Google Scholar]
  86. , . Drug treatment in dementia. Curr Opin Psychiatry. 2001;14:349-53.
    [Google Scholar]
Show Sections